A promising weapon against measles
Researchers at LJI and Columbia University uncover exactly how a neutralizing antibody blocks measles virus infection
Researchers at LJI and Columbia University uncover exactly how a neutralizing antibody blocks measles virus infection
“We’re glad to continue our support for this cross-border partnership and expand our work with young scientists and research leaders just across the border.”
LJI scientists share their visions for more effective, longer-lasting vaccines
A 'cocktail' of human antibodies shows promise in fighting severe SARS-CoV-2 infections
LJI scientists share high-resolution view of the lymphocytic choriomeningitis virus (LCMV) glycoprotein together with a neutralizing antibody
A new study led by scientists at La Jolla Institute for Immunology (LJI) shows how ideal antibodies against SARS-CoV-2 hit their marks.
LA JOLLA—Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don’t realize
Dawid Zyla, Ph.D., is an immunologist and a skilled photographer. He shares a stunning look at the technical marvels behind biomedical research.
LA JOLLA, CA—Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its
LJI-led Coronavirus Immunotherapeutic Consortium identifies antibody 'communities' with power to stop SARS-CoV-2 variants
5 takeaways from February's "Live from the Lab" webinar
Most coronaviruses usually cause the common cold, but, as happened with the SARS virus in 2003 and the MERS virus